Randall E Merchant

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. ncbi request reprint Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study
    R E Merchant
    Departments of Anatomy and Internal Medicine, Virginia Commonwealth University, Medical College of Virginia Richmond, VA 23298 0709, USA
    Phytother Res 14:167-73. 2000
  2. ncbi request reprint A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis
    R E Merchant
    Virginia Commonwealth University, Medical College of Virginia, Richmond, VA 23298 0709, USA
    Altern Ther Health Med 7:79-91. 2001
  3. ncbi request reprint Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension
    Randall E Merchant
    Department of Anatomy and Internal Medicine, Virginia Commonwealth University, Medical College of Virginia, Richmond, VA 23298 0709, USA
    J Med Food 5:141-52. 2002
  4. ncbi request reprint Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression
    Robert M Prins
    Department of Anatomy, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, MCV Station, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:190-9. 2002
  5. ncbi request reprint Outcome measures for clinical trials in neurotrauma
    M Ross Bullock
    Division of Neurosurgery, Medical College of Virginia, Richmond, Virgina 23298 0631, USA
    Neurosurg Focus 13:ECP1. 2002
  6. ncbi request reprint Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery
    Martin R Graf
    Department of Anatomy and Neurobiology, Medical College of Virginia, Virginia Commonwealth University, P O Box 980709 MCV Station, Richmond, VA 23298 0709, USA
    J Neuroimmunol 140:49-60. 2003
  7. ncbi request reprint Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat
    Monica R Hazelrigg
    Department of Anatomy, Virginia Commonwealth University, Medical College of Virginia, Richmond, VA 23298 0631, USA
    J Neurooncol 60:143-50. 2002
  8. ncbi request reprint Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination
    Martin R Graf
    Department of Anatomy and Division of Neurosurgery, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:179-89. 2002
  9. ncbi request reprint Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas
    Martin R Graf
    Department of Neurosurgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298 0631, USA
    J Neurooncol 73:29-36. 2005
  10. ncbi request reprint Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression
    Robert M Prins
    Department of Anatomy and Surgery, Virginia Commonwealth University Medical College of Virginia, Richmond, VA, USA
    J Neurooncol 64:45-54. 2003

Detail Information

Publications10

  1. ncbi request reprint Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study
    R E Merchant
    Departments of Anatomy and Internal Medicine, Virginia Commonwealth University, Medical College of Virginia Richmond, VA 23298 0709, USA
    Phytother Res 14:167-73. 2000
    ....
  2. ncbi request reprint A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis
    R E Merchant
    Virginia Commonwealth University, Medical College of Virginia, Richmond, VA 23298 0709, USA
    Altern Ther Health Med 7:79-91. 2001
    ..One example is dietary supplements derived from Chlorella pyrenoidosa, a unicellular fresh water green alga rich in proteins, vitamins, and minerals...
  3. ncbi request reprint Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension
    Randall E Merchant
    Department of Anatomy and Internal Medicine, Virginia Commonwealth University, Medical College of Virginia, Richmond, VA 23298 0709, USA
    J Med Food 5:141-52. 2002
    ..The results indicate that, for some subjects with mild to moderate hypertension, a daily dietary supplement of Chlorella reduced or kept stable their SiDBP...
  4. ncbi request reprint Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression
    Robert M Prins
    Department of Anatomy, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, MCV Station, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:190-9. 2002
    ..Therefore, we believe that an MSC population is responsible for inhibiting the anti-tumor T cell response, resulting in the enhanced growth of the i.c. glioma, and may represent a significant obstacle to immune-based therapies...
  5. ncbi request reprint Outcome measures for clinical trials in neurotrauma
    M Ross Bullock
    Division of Neurosurgery, Medical College of Virginia, Richmond, Virgina 23298 0631, USA
    Neurosurg Focus 13:ECP1. 2002
    ....
  6. ncbi request reprint Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery
    Martin R Graf
    Department of Anatomy and Neurobiology, Medical College of Virginia, Virginia Commonwealth University, P O Box 980709 MCV Station, Richmond, VA 23298 0709, USA
    J Neuroimmunol 140:49-60. 2003
    ..F cells. Intracranial T9.F/IL2/#12 tumors were markedly infiltrated by CD4(+) and CD8(+) T cells, natural killer (NK)-T cells and myeloid progenitor cells, whereas subcutaneous T9.F/IL2/#12 tumors contained an elevated level of NK cells...
  7. ncbi request reprint Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat
    Monica R Hazelrigg
    Department of Anatomy, Virginia Commonwealth University, Medical College of Virginia, Richmond, VA 23298 0631, USA
    J Neurooncol 60:143-50. 2002
    ..These data demonstrate that tumor-sensitized lymphocytes traffic to an intracerebral target site where they can exert an effect, further supporting adoptive immunotherapy as a treatment for glioma...
  8. ncbi request reprint Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination
    Martin R Graf
    Department of Anatomy and Division of Neurosurgery, Virginia Commonwealth University Medical College of Virginia, 1101 E Marshall Street, P O Box 980709, Richmond, VA 23198 0709, USA
    Cancer Immunol Immunother 51:179-89. 2002
    ....
  9. ncbi request reprint Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas
    Martin R Graf
    Department of Neurosurgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298 0631, USA
    J Neurooncol 73:29-36. 2005
    ..These results suggest that MSC infiltration and unregulated tumor growth in response to vaccination is T cell-dependent; is not unique to the T9 glioma; and can be recapitulated with an alternate immunization approach...
  10. ncbi request reprint Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression
    Robert M Prins
    Department of Anatomy and Surgery, Virginia Commonwealth University Medical College of Virginia, Richmond, VA, USA
    J Neurooncol 64:45-54. 2003
    ..Our findings may shed light on the significance of thymic function for anti-glioma immunity and the response to immunotherapeutic treatment paradigms...